Eli Lilly Expands Veeva Partnership with Global Vault CRM Adoption
Event summary
- Veeva Systems announced on August 11, 2026 that Eli Lilly has committed to Veeva Vault CRM globally.
- Vault CRM is part of the Vault CRM Suite, which supports agentic commercial models leveraging AI for patient outreach.
- Giuseppe Firenze, senior vice president at Lilly, stated Vault CRM will help bring breakthrough medicines to more patients.
- Veeva serves over 1,500 customers in the life sciences industry.
The big picture
This partnership underscores the growing trend of AI-driven commercial models in the life sciences industry. As pharma companies seek to optimize patient outreach, Veeva's Vault CRM Suite positions itself as a key enabler. The global adoption by Eli Lilly highlights the strategic importance of digital transformation in healthcare.
What we're watching
- AI Adoption Pace
- How quickly Eli Lilly and other pharma companies will integrate AI-driven commercial models.
- Market Expansion
- Whether Veeva can sustain growth by securing more large-scale partnerships in the life sciences sector.
- Competitive Dynamics
- The impact of this deal on competitors offering similar CRM solutions for pharmaceutical companies.
Related topics